Alaunos Therapeutics reported $921K in Current Liabilities for its fiscal quarter ending in September of 2025.





Current Liabilities Change Date
Alaunos Therapeutics USD 921K 153K Sep/2025
Amgen USD 25.49B 3.7B Dec/2025
AstraZeneca USD 30.62B 3.44B Dec/2025
Baxter International USD 2.97B 805M Dec/2025
Biogen USD 3.35B 59.4M Dec/2025
Bioline Rx USD 13.67M 1.81M Sep/2025
Bristol-Myers Squibb USD 28.14B 608M Sep/2025
Celltrion KRW 4.01T 343.96B Sep/2025
Corcept Therapeutics USD 166.08M 6.18M Dec/2025
Cspc Pharmaceutical CNY 10.18B 65.36M Dec/2025
Curis USD 14.08M 5.3M Dec/2025
Deva Holding AS TRY 6.43B 1.18B Sep/2023
Dianthus Therapeutics USD 30.73M 6.88M Dec/2025
Divis Laboratories Ltd INR 17.28B 2.76B Sep/2025
Gilead Sciences USD 11.81B 485M Dec/2025
GlaxoSmithKline GBP 21.39B 57M Dec/2025
Incyte USD 1.52B 176.44M Dec/2025
Intrexon USD 23.02M 38K Jun/2024
Ionis Pharmaceuticals USD 783M 120.46M Dec/2025
J&J USD 54.13B 3.26B Dec/2025
Kangmei Pharma CNY 5.81B 57.93M Sep/2025
Karyopharm Therapeutics USD 92.06M 4.9M Dec/2025
Knight Therapeutics CAD 165.26M 12.58M Dec/2025
Laboratorios Farma EUR 199.84M 121.75M Dec/2023
Malin Corporation EUR 1000K 500K Dec/2024
Medical Developments International AUD 5.56M 2.26M Dec/2025
Merck USD 28.63B 2.59B Sep/2025
Neuren Pharmaceuticals AUD 4.34M 3.58M Dec/2025
Novartis USD 27.28B 4.72B Dec/2025
Organigram Holdings CAD 94.05M 32.11M Dec/2025
Ovoca Bio EUR 186K 2.26M Jun/2025
Pfizer USD 36.6B 1.13B Sep/2025
Pharma Mar EUR 93.88M 4.94M Dec/2025
PTC Therapeutics USD 968.43M 102.18M Dec/2025
Qiagen NV USD 512.14M 461.26M Dec/2025
Regeneron Pharmaceuticals USD 4.37B 56.7M Dec/2025
Roche Holding CHF 28B 421M Dec/2025
Sangamo BioSciences USD 47.66M 1.9M Jun/2025
Sartorius EUR 1.81B 254.3M Sep/2025
Sino Biopharmaceutical CNY 24.85B 5.29B Jun/2025
TG Therapeutics USD 153.76M 3.05M Dec/2025
Tilray USD 259.32M 8.32M Sep/2025
Verastem USD 72.27M 12.56M Dec/2025
Zealand Pharma A/S 664.96M 513.61M Dec/2025
Zz Pientze Pharmaceu CNY 2.14B 1.06B Sep/2025